Miscellaneous
This podcast series is sponsored by Vectra®. Discussion does not constitute or imply endorsement of the product. In this episode, Adam J. Brown, MD, and Jeffrey Curtis, MD, discuss the multiple biomarkers associated with cardiovascular risk in rheumatoid arthritis, as well as the reasoning behind the development of a biomarker-based cardiovascular risk model. Intro :10 Intro of Dr. Jeffrey Curtis :22 Today’s episode :56 Tell us about your background and how you got to where you are? 3:29 What do rheumatologists need to be using other than existing score-based systems to predict cardiovascular risk? 5:06 Are traditional risk factor calculators helpful? What are they missing? 6:32 Considering disease level/activity when looking at overall cardiovascular risk 8:07 A high-level look at multiple biomarker-based tests 9:38 How were the 12 individual biomarkers originally selected? 11:42 How do you go about implementing the test? How do you get patients? 17:23 How is the test ordered and how do you walk a patient through it? 19:48 How is the timeframe based? 21:56 When are physicians ordering this test? 23:46 The use of biomarker information in educating patients about additional risk factors 26:36 What’s going into the score generated by test? 27:36 How to use the resulting score in conversations with patients 28:19 Additional work and responsibility for rheumatologists as a result of this test being available 30:16 Thanks for listening 33:17 Additional work and responsibility for rheumatologists as a result of this test being available 31:45 Thanks for listening 34:50